Intel announced on August 22, 2025 that it had reached an agreement with the Trump administration under which the U.S. government would make an 8.9 billion dollar investment in Intel common stock, converting funds previously committed under the CHIPS and Science Act and the Secure Enclave program into an equity position instead of grant disbursements.
The deal gives the federal government roughly a 10% stake in Intel, making it one of the company's largest shareholders, according to Reuters' reporting on the announcement. President Trump characterized the arrangement as getting a return for the American taxpayer on money that would otherwise have been paid out as a straightforward subsidy.
Why it matters
The 2022 CHIPS Act was designed to hand out grants and tax credits to rebuild domestic semiconductor manufacturing, not to make Washington a shareholder in the companies it subsidizes. Turning grant money into equity blurs a line policymakers had generally tried to keep separate — between the government as regulator and funder, and the government as an owner with a financial stake in a company's stock price and competitive fortunes.
How the rule works
Rather than disbursing the remaining CHIPS Act award and Secure Enclave funding that Intel was already entitled to under its 2024 preliminary agreements, the administration restructured the payment as a purchase of newly issued Intel common stock, priced using a formula tied to recent trading levels. The shares reportedly come with limited or no voting rights attached to the government's ordinary governance influence, according to Intel's announcement, though the exact governance terms drew close attention from securities analysts.
Evidence
Intel's own press release, filed with securities regulators, confirms the 8.9 billion dollar equity investment figure and describes it as building on the company's more than 100 billion dollar U.S. manufacturing expansion. AP News reported the government's total stake was built from 11.1 billion dollars in combined federal funds converted into the roughly 10% position.
The competing read
Supporters of the deal, including the administration, argue it lets taxpayers share in Intel's potential turnaround rather than handing out money with no upside, especially given Intel's struggles to compete with TSMC and Samsung in advanced manufacturing. Critics, including some economists and policy analysts cited by PBS NewsHour, have warned the arrangement sets a precedent for government intervention in individual company ownership, raises questions about whether other CHIPS Act recipients such as TSMC, Samsung and Micron might face similar pressure, and could complicate Intel's competitive position if rivals argue the deal amounts to a subsidy advantage.
What happens next
Analysts are watching whether other chipmakers that received CHIPS Act awards face pressure to accept similar equity-for-grant conversions, and whether Congress moves to legislate guardrails around future federal equity stakes in private companies tied to industrial policy programs.